Novo Nordisk A/S: Turner Syndrome trials
The registry lists 12 Turner Syndrome studies with Novo Nordisk A/S as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 3 5Phase 4 3No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9Active, not recruitingNCT05723835Phase 3Results posted
- Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCompletedNCT01245374Phase 4Results posted
- A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to GrowActive, not recruitingNCT05330325Phase 3
- Growth Response in Girls With Turner SyndromeCompletedNCT01734486Phase 4
- Induction of Puberty With 17-beta Estradiol in Girls With Turner SyndromeCompletedNCT01710696Phase 3
- Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner SyndromeCompletedNCT01604161
- Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNCT01563926Phase 3
- Safety and Efficacy of Long-term Somatropin Treatment in ChildrenCompletedNCT01543867
- Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner SyndromeCompletedNCT01518062Phase 4
- Use of Somatropin in Turner SyndromeCompletedNCT01518036Phase 3
- Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth HormoneCompletedNCT01327924
- Observational Prospective Study on Patients Treated With Norditropin®CompletedNCT00960128